Biocept, Inc. (Biocept) is a privately-held biotechnology company. The company is engaged in the development of diagnostic assay products for life science research and in-vitro diagnostic markets. Biocept develops cell separation technology, an innovative class of diagnostic assays for personalized medicine in early detection, diagnosis and monitoring of cancer. The company develops diagnostic products using its CEE technology to detect circulating ovarian cancer cells. In addition, the company entered into collaborations with several academic institutions and pharmaceutical to explore the application of the CEE system. The laboratory is accredited by the College of American Pathologists (CAP). Biocept is headquartered in California, the US.

Street: 
5810 Nancy Ridge Drive
City: 
San Diego
Postcode: 
92121
Federal State : 
United States
WebSite: 
www.biocept.com
Fax: 
1-858-3208225

Company Index Score

Current Index Score Historical Index Score
  • Biocept, Inc. currently scores 50 % in the index.
  • Biocept, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Biocept, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets